News & Updates

Show Multimedia Only
ADHD medication use carries no excess risk of cardiovascular diseases

ADHD medication use carries no excess risk of cardiovascular diseases

02 Dec 2022

Users of attention-deficit/hyperactivity disorder (ADHD) medications across age groups do not appear to be at increased risk of cardiovascular diseases (CVDs), although a modest risk increase of cardiac arrest or tachyarrhythmias could not be ruled out, according to the results of a meta-analysis.

ADHD medication use carries no excess risk of cardiovascular diseases

02 Dec 2022
SG, HK docs delay prescribing clozapine for treatment-resistant schizophrenia

SG, HK docs delay prescribing clozapine for treatment-resistant schizophrenia

02 Dec 2022
ENT-01 relieves constipation in patients with Parkinson’s disease

ENT-01 relieves constipation in patients with Parkinson’s disease

02 Dec 2022
Maximum home BP predicts cardiovascular outcomes in T2D patients

Maximum home BP predicts cardiovascular outcomes in T2D patients

02 Dec 2022

In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.

Maximum home BP predicts cardiovascular outcomes in T2D patients

02 Dec 2022
IV iron cuts risk of HF rehospitalization, CV death in ambulatory HFrEF patients

IV iron cuts risk of HF rehospitalization, CV death in ambulatory HFrEF patients

02 Dec 2022
Esophagogastric junction biopsy may be forgone after endoscopic eradication of BE

Esophagogastric junction biopsy may be forgone after endoscopic eradication of BE

02 Dec 2022